BlueCrest Capital Management’s Allergan plc AGN Stock Holding History

BlueCrest Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,594	Closed	-$6.33M	–	673
2019 Q3	$6.33M	Buy	37,594 +23,383	+165%	+$3.81M	0.44%	54
2019 Q2	$2.38M	Buy	14,211 +10,911	+331%	+$1.51M	0.17%	90
2019 Q1	$483K	Buy	+3,300	New	+$478K	0.02%	505
2018 Q4	–	Sell	-28,422	Closed	-$5.41M	–	1644
2018 Q3	$5.41M	Buy	+28,422	New	+$5.22M	0.14%	103
2017 Q3	–	Sell	-1,520	Closed	-$369K	–	1183
2017 Q2	$369K	Buy	+1,520	New	+$357K	0.01%	656
2017 Q1	–	Sell	-6,957	Closed	-$1.46M	–	1010
2016 Q4	$1.46M	Buy	+6,957	New	+$1.44M	0.08%	307
2015 Q4	–	Sell	-19,330	Closed	-$5.25M	–	1260
2015 Q3	$5.25M	Sell	19,330 -19,370	-50%	-$5.95M	0.17%	108
2015 Q2	$11.7M	Sell	38,700 -3,585	-8%	-$1.07M	0.34%	40
2015 Q1	$12.6M	Buy	+42,285	New	+$12.1M	0.68%	25

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlueCrest Capital Management's AGN Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 37,594 shares — an estimated $6.33M sold.

BlueCrest Capital Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $12.6M in Q1 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

BlueCrest Capital Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
BlueCrest Capital Management sold 37,594 Allergan plc shares in Q4 2019, an estimated $6.33M.
BlueCrest Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
BlueCrest Capital Management's Allergan plc position peaked at $12.6M in Q1 2015.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.